<DOC>
	<DOCNO>NCT02867085</DOCNO>
	<brief_summary>The prospective BoHemE study design evaluate correlation bone marrow function skeletal health elderly patient ( &gt; = 60 year ) without pre-existing myelodysplastic syndrome ( MDS ) .</brief_summary>
	<brief_title>Study Investigating Interactions Bone Hematopoiesis Elderly</brief_title>
	<detailed_description />
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>Inclusion Criteria Group 1 ( MDS group ) : Age ≥60 year With know suspected MDS ( accord WHO , ＜20 % blast count ) Written informed consent Inclusion Criteria Group 2 ( control group ) : Age ≥60 year Undergoing elective knee hip replacement therapy Normal blood count ( define Hb ♀ &gt; 12 g/dL , ♂ &gt; 13 g/dL ; ANC &gt; 1.8x10^9/L ; PLT &gt; 100x10^9/L ) Written informed consent Exclusion Criteria Group 1 ( MDS group ) + 2 ( control group ) : Patients previously underwent bilateral total hip replacement patient control group diagnose MDS AML prior study exclude . In addition , patient dementia ( MMSE score &lt; 24 ) , renal insufficiency eGFR &lt; 45 mL/min , liver cirrhosis ChildPugh B C , active infection ( HIV , hepatitis B C , tuberculosis ) , heart insufficiency NYHA III IV , severe cardiac valve disease eligible study . Moreover , participant able consent exclude BoHemE study .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>MDS</keyword>
	<keyword>Myelodysplastic Syndromes</keyword>
</DOC>